Application of Weighted Interaction-Fingerprints for Rationalizing Neosubstrate Potency and Selectivity of

Guilian Luchini1, Shuang Liu1, Hannah L Powers1

  • 1Discovery & Development Sciences, Bristol Myers Squibb Company, 10300 Campus Point Drive Suite 100, San Diego, California 92121, United States.

PubMed
Summary

Cereblon E3 ligase modulatory drugs (CELMoDs) successfully target proteins for degradation. This study introduces a computational method to design more selective and effective CRBN-based molecular glues by analyzing neosubstrate interactions.